SynthesisCardiovascular diabetology2016

Major adverse cardiovascular events with basal insulin peglispro versus comparator insulins in patients with type 1 or type 2 diabetes: a meta-analysis.

Byron J Hoogwerf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.